Cesca Therapeutics (KOOL) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Cesca Therapeutics (KOOL) Receives U.S. Patent Related to Stem Cell Compositions
June 23, 2015 6:04 AM EDTCesca Therapeutics (NASDAQ: KOOL) announced the issuance of U.S. Patent No. 9,050,422 by the U.S. Patent and Trademark Office. The patent for "Stem and Progenitor Cell Compositions Recovered from Bone Marrow or Cord Blood" is a divisional for U.S. Patent No.... More
